Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Marinus Pharmaceuticals Inc’s stock clocked out at $0.53, down -0.21% from its previous closing price of $0.54. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 2.91 million shares were traded. MRNS stock price reached its highest trading level at $0.5427 during the session, while it also had its lowest trading level at $0.521.
Ratios:
To gain a deeper understanding of MRNS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.66.
Robert W. Baird Downgraded its Outperform to Neutral on April 16, 2024, whereas the target price for the stock was revised from $20 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 10 ’24 when Saraswathy Nochur bought 13,250 shares for $0.28 per share.
Pfanstiel Steven sold 4,657 shares of MRNS for $5,262 on Aug 05 ’24. The CFO AND COO now owns 79,773 shares after completing the transaction at $1.13 per share. On Aug 05 ’24, another insider, Shafer Christina, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 3,820 shares for $1.14 each. As a result, the insider received 4,355 and left with 67,406 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRNS now has a Market Capitalization of 29486678 and an Enterprise Value of 50216484. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94. Its current Enterprise Value per Revenue stands at 1.659 whereas that against EBITDA is -0.39.
Stock Price History:
Over the past 52 weeks, MRNS has reached a high of $11.26, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 41.98%, while the 200-Day Moving Average is calculated to be -70.65%.
Shares Statistics:
It appears that MRNS traded 3.16M shares on average per day over the past three months and 4355270 shares per day over the past ten days. A total of 55.19M shares are outstanding, with a floating share count of 41.87M. Insiders hold about 24.13% of the company’s shares, while institutions hold 62.83% stake in the company. Shares short for MRNS as of 1730332800 were 5664347 with a Short Ratio of 1.36, compared to 1727654400 on 3221631. Therefore, it implies a Short% of Shares Outstanding of 5664347 and a Short% of Float of 10.319999600000001.
